Litcius/Paper detail

Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT)

Narges Maleki, Negar Yavari, Maryam Ebrahimi, Ahmad Faisal Faiz, Roya Khosh Ravesh, Aysan Sharbati, Mohammad Panji, Keivan Lorian, Abdollah Gravand, Mojtaba Abbasi, Omid Abazari, Mehdi Shafiee Mehr, Yasin Eskandari

2022Gene26 citationsDOI

Topics & Concepts

SilibininBiologyEpithelial–mesenchymal transitionCancer researchVimentinOvarian cancerViability assayApoptosisCancer cellPI3K/AKT/mTOR pathwayProtein kinase BIn vivoCell growthCancerImmunologyMetastasisBiochemistryImmunohistochemistryGeneticsSilymarin and Mushroom PoisoningCurcumin's Biomedical ApplicationsFlavonoids in Medical Research
Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT) | Litcius